TDAM USA’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $1.83M | Sell |
8,125
-425
| -5% | -$89.7K | 0.11% | 126 |
|
|
2021
Q3 | $1.82M | Buy |
8,550
+778
| +10% | +$179K | 0.12% | 125 |
|
|
2021
Q2 | $1.88M | Sell |
7,772
-1,501
| -16% | -$369K | 0.12% | 128 |
|
|
2021
Q1 | $2.31M | Sell |
9,273
-29
| -0.3% | -$6.92K | 0.14% | 126 |
|
|
2020
Q4 | $2.14M | Sell |
9,302
-227
| -2% | -$52.3K | 0.13% | 129 |
|
|
2020
Q3 | $2.42M | Sell |
9,529
-172
| -2% | -$42.6K | 0.17% | 121 |
|
|
2020
Q2 | $2.25M | Buy |
9,701
+115
| +1% | +$26.2K | 0.16% | 126 |
|
|
2020
Q1 | $1.94M | Buy |
9,586
+368
| +4% | +$80.4K | 0.16% | 125 |
|
|
2019
Q4 | $2.22M | Sell |
9,218
-281
| -3% | -$61.9K | 0.14% | 133 |
|
|
2019
Q3 | $1.84M | Sell |
9,499
-2,164
| -19% | -$415K | 0.13% | 141 |
|
|
2019
Q2 | $2.15M | Sell |
11,663
-780
| -6% | -$140K | 0.15% | 124 |
|
|
2019
Q1 | $2.36M | Buy |
12,443
+643
| +5% | +$123K | 0.17% | 112 |
|
|
2018
Q4 | $2.3M | Sell |
11,800
-1,003
| -8% | -$196K | 0.17% | 115 |
|
|
2018
Q3 | $2.5M | Sell |
12,803
-94
| -0.7% | -$18.5K | 0.15% | 120 |
|
|
2018
Q2 | $2.38M | Sell |
12,897
-73
| -0.6% | -$12.9K | 0.15% | 119 |
|
|
2018
Q1 | $2.21M | Sell |
12,970
-280
| -2% | -$51.4K | 0.13% | 121 |
|
|
2017
Q4 | $2.3M | Buy |
13,250
+495
| +4% | +$87.6K | 0.13% | 121 |
|
|
2017
Q3 | $2.38M | Sell |
12,755
-47,430
| -79% | -$8.4M | 0.14% | 119 |
|
|
2017
Q2 | $10.4M | Buy |
60,185
+449
| +0.8% | +$73K | 0.54% | 64 |
|
|
2017
Q1 | $9.8M | Sell |
59,736
-496
| -0.8% | -$82.4K | 0.5% | 72 |
|
|
2016
Q4 | $8.81M | Sell |
60,232
-1,029
| -2% | -$155K | 0.46% | 73 |
|
|
2016
Q3 | $10.2M | Sell |
61,261
-206
| -0.3% | -$34.8K | 0.51% | 66 |
|
|
2016
Q2 | $9.35M | Sell |
61,467
-351
| -0.6% | -$54.6K | 0.46% | 71 |
|
|
2016
Q1 | $9.27M | Buy |
61,818
+289
| +0.5% | +$42.9K | 0.45% | 76 |
|
|
2015
Q4 | $9.99M | Buy |
61,529
+21
| +0% | +$3.3K | 0.48% | 74 |
|
|
2015
Q3 | $8.51M | Buy |
61,508
+1,165
| +2% | +$184K | 0.43% | 75 |
|
|
2015
Q2 | $9.26M | Sell |
60,343
-4,327
| -7% | -$693K | 0.42% | 78 |
|
|
2015
Q1 | $10.3M | Buy |
64,670
+282
| +0.4% | +$44.4K | 0.42% | 81 |
|
|
2014
Q4 | $10.3M | Buy |
64,388
+411
| +0.6% | +$64K | 0.43% | 81 |
|
|
2014
Q3 | $8.99M | Sell |
63,977
-251
| -0.4% | -$32.8K | 0.39% | 87 |
|
|
2014
Q2 | $7.6M | Sell |
64,228
-267
| -0.4% | -$30.9K | 0.32% | 103 |
|
|
2014
Q1 | $7.95M | Buy |
64,495
+319
| +0.5% | +$38.7K | 0.35% | 100 |
|
|
2013
Q4 | $7.32M | Buy |
64,176
+53,233
| +486% | +$6.06M | 0.32% | 98 |
|
|
2013
Q3 | $1.22M | Sell |
10,943
-53,627
| -83% | -$5.81M | 0.06% | 130 |
|
|
2013
Q2 | $6.49M | Buy |
+64,570
| New | +$6.7M | 0.3% | 88 |
|
Other funds holding AMGN
TDAM USA's AMGN Position: Q4 2021 in Review
TDAM USA reduced its Amgen (AMGN) stake by 5% in Q4 2021, selling an estimated $89.7K and leaving 8,125 shares worth $1.83M. The position accounts for 0.11% of the portfolio, ranked #126.
TDAM USA first reported a position in AMGN in Q2 2013 and has held it in 35 quarters since. The position peaked at $10.4M in Q2 2017. 2,294 funds tracked by Wall St. Rank hold AMGN as of Q4 2021.
- TDAM USA held 8,125 shares of Amgen worth $1.83M as of Q4 2021.
- TDAM USA sold 425 Amgen shares in Q4 2021, an estimated $89.7K.
- Amgen made up 0.11% of TDAM USA's portfolio in Q4 2021, its #126 holding.
- TDAM USA first reported a position in Amgen in Q2 2013 and has held it in 35 quarters since.
- TDAM USA's Amgen position peaked at $10.4M in Q2 2017.
- 2,294 funds tracked by Wall St. Rank held Amgen as of Q4 2021.
Based on TDAM USA's 13F filing for Q4 2021, filed 10 Feb 2022.